Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2017 1
2018 2
2019 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.
Howard JF Jr, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I, Jacob S, Vissing J, Burns TM, Kissel JT, Muppidi S, Nowak RJ, O'Brien F, Wang JJ, Mantegazza R; REGAIN Study Group. Howard JF Jr, et al. Lancet Neurol. 2017 Dec;16(12):976-986. doi: 10.1016/S1474-4422(17)30369-1. Epub 2017 Oct 20. Lancet Neurol. 2017. PMID: 29066163 Clinical Trial.
Routine Cerebrospinal Fluid Cytology Reveals Unique Inclusions in Macrophages During Treatment With Nusinersen.
Gingele S, Hümmert MW, Alvermann S, Jendretzky KF, Bönig L, Brieskorn M, Schwenkenbecher P, Sühs KW, Müschen LH, Osmanovic A, Schreiber-Katz O, Stangel M, Petri S, Skripuletz T. Gingele S, et al. Among authors: alvermann s. Front Neurol. 2019 Jul 11;10:735. doi: 10.3389/fneur.2019.00735. eCollection 2019. Front Neurol. 2019. PMID: 31354609 Free PMC article.
Immunophenotyping of cerebrospinal fluid cells by Chipcytometry.
Hümmert MW, Alvermann S, Gingele S, Gross CC, Wiendl H, Mirenska A, Hennig C, Stangel M. Hümmert MW, et al. Among authors: alvermann s. J Neuroinflammation. 2018 May 25;15(1):160. doi: 10.1186/s12974-018-1176-7. J Neuroinflammation. 2018. PMID: 29801453 Free PMC article.
Ocrelizumab Depletes CD20⁺ T Cells in Multiple Sclerosis Patients.
Gingele S, Jacobus TL, Konen FF, Hümmert MW, Sühs KW, Schwenkenbecher P, Ahlbrecht J, Möhn N, Müschen LH, Bönig L, Alvermann S, Schmidt RE, Stangel M, Jacobs R, Skripuletz T. Gingele S, et al. Among authors: alvermann s. Cells. 2018 Dec 28;8(1):12. doi: 10.3390/cells8010012. Cells. 2018. PMID: 30597851 Free PMC article.
Botulinum neurotoxin serotype D - A potential treatment alternative for BoNT/A and B non-responding patients.
Kutschenko A, Weisemann J, Kollewe K, Fiedler T, Alvermann S, Böselt S, Escher C, Garde N, Gingele S, Kaehler SB, Karatschai R, Krüger THC, Sikorra S, Tacik P, Wegner F, Wollmann J, Bigalke H, Wohlfarth K, Rummel A. Kutschenko A, et al. Among authors: alvermann s. Clin Neurophysiol. 2019 Jun;130(6):1066-1073. doi: 10.1016/j.clinph.2019.02.007. Epub 2019 Feb 28. Clin Neurophysiol. 2019. PMID: 30871800